Scheme For Strengthening of Pharmaceutical Industry

• 12 Mar 2022

On 11^th March, 2022, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers released the guidelines for the scheme “Strengthening of Pharmaceutical Industry (SPI)".

Aim

• To strengthen the existing infrastructure facilities in order to make India a global leader in the Pharma Sector.

Salient Features

• Under the Scheme, financial assistance to pharma clusters will be provided for creation of Common Facilities. This will not only improve the quality but also ensure the sustainable growth of clusters.
• Further, in order to upgrade the production facilities of SMEs and MSMEs so as to meet national and international regulatory standards (WHO-GMP or Schedule-M), interest subvention or capital subsidy on their capital loans will be provided, which will further facilitate the growth in volumes as well as in quality.

3 Components

• Assistance to Pharmaceutical Industry for Common Facilities (APICF): To strengthen the existing pharmaceutical clusters’ capacity for their sustained growth by creating common facilities.
• Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS): To facilitate Micro, Small and Medium Pharma Enterprises (MSMEs) of proven track record to meet national and international regulatory standards.
• Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS): To facilitate growth and development of Pharmaceutical and Medical Devices Sectors through study/survey reports, awareness programs, creation of database, and promotion of industry.

Impact

• Quality and Technology Upgradation: It is expected that the units supported under this scheme will act as Demonstration Firms for the pharma clusters and MSE Pharma Industries, to develop on quality and technology upgradation fronts.
• Improving, Productivity, Quality and Sustainability: It will help to address the rising demand in terms of support required to existing Pharma clusters and MSMEs across the country to improve their productivity, quality and sustainability.
• Establishing India as a Global Leader: Scheme will contribute to establish India a global leader in Pharma Sector by providing financial assistance to Pharma clusters for creation of Common